111 related articles for article (PubMed ID: 7880073)
1. Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma.
Imai A; Ohno T; Ohsuye K; Tamaya T
Ann Clin Biochem; 1994 Nov; 31 ( Pt 6)():550-5. PubMed ID: 7880073
[TBL] [Abstract][Full Text] [Related]
2. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.
Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
Gynecol Oncol; 1994 Oct; 55(1):144-8. PubMed ID: 7959256
[TBL] [Abstract][Full Text] [Related]
3. Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma.
Ohno T; Imai A; Furui T; Takahashi K; Tamaya T
Am J Obstet Gynecol; 1993 Sep; 169(3):605-10. PubMed ID: 8103967
[TBL] [Abstract][Full Text] [Related]
4. Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas.
Takagi H; Imai A; Furui T; Horibe S; Fuseya T; Tamaya T
Gynecol Oncol; 1995 Jul; 58(1):110-5. PubMed ID: 7789876
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types.
Imai A; Ohno T; Iida K; Fuseya T; Furui T; Tamaya T
Cancer; 1994 Nov; 74(9):2555-61. PubMed ID: 7522953
[TBL] [Abstract][Full Text] [Related]
6. Lack of evidence for aromatase expression in human ovarian epithelial carcinoma.
Imai A; Ohno T; Takahashi K; Furui T; Tamaya T
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():65-71. PubMed ID: 8154854
[TBL] [Abstract][Full Text] [Related]
7. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
Bi SN; Dai SZ; Yao Q; Che YC; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
[TBL] [Abstract][Full Text] [Related]
8. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma.
Irmer G; Bürger C; Müller R; Ortmann O; Peter U; Kakar SS; Neill JD; Schulz KD; Emons G
Cancer Res; 1995 Feb; 55(4):817-22. PubMed ID: 7850795
[TBL] [Abstract][Full Text] [Related]
9. Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane.
Imai A; Takagi H; Furui T; Horibe S; Fuseya T; Tamaya T
Cancer; 1996 Jan; 77(1):132-7. PubMed ID: 8630919
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for expression of Fas ligand in Fas-bearing tumors.
Takagi A; Imai A; Horibe S; Ohno T; Tamaya T
Oncol Rep; 1998; 5(2):377-80. PubMed ID: 9468561
[TBL] [Abstract][Full Text] [Related]
11. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma].
Li PL; Liu MM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365
[TBL] [Abstract][Full Text] [Related]
12. Expression of the endothelial cell differentiation gene 7 (EDG-7), a lysophosphatidic acid receptor, in ovarian tumor.
Nakamoto T; Yasuda K; Yasuhara M; Yoshimura T; Kinoshita T; Nakajima T; Okada H; Ikuta A; Kanzaki H
J Obstet Gynaecol Res; 2005 Aug; 31(4):344-51. PubMed ID: 16018784
[TBL] [Abstract][Full Text] [Related]
13. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
Feng QL; Shi HR; Qiao LJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
15. Implantation and growth of epidermal growth factor (EGF) receptor expressing human ovarian cancer xenografts in nude mice is dependent on EGF.
Kurachi H; Morishige K; Adachi H; Adachi K; Tasaka K; Sawada M; Miyake A
Cancer; 1994 Dec; 74(11):2984-90. PubMed ID: 7954262
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
Yang YQ; Li JC
Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
[TBL] [Abstract][Full Text] [Related]
17. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells.
Imai A; Furui T; Tamaya T; Mills GB
J Clin Endocrinol Metab; 2000 Sep; 85(9):3370-5. PubMed ID: 10999836
[TBL] [Abstract][Full Text] [Related]
18. [Expression of RASSF1A and RASSF1C transcripts in human primary ovarian cancers].
Ma L; Zhang JH; Liu FR; Zhang X
Zhonghua Bing Li Xue Za Zhi; 2005 Mar; 34(3):150-3. PubMed ID: 15938825
[TBL] [Abstract][Full Text] [Related]
19. Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer.
Reimer D; Steppan I; Wiedemair A; Concin N; Hofstetter G; Marth C; Müller-Holzner E; Zeimet AG
Int J Cancer; 2007 Jun; 120(12):2568-75. PubMed ID: 17278108
[TBL] [Abstract][Full Text] [Related]
20. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.
Wang J; Cai J; Han F; Yang C; Tong Q; Cao T; Wu L; Wang Z
Int J Gynecol Cancer; 2011 Aug; 21(6):981-7. PubMed ID: 21738044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
